GEN Exclusives

More »

GEN Poll

More »
Jul 08, 2014

FDA Weighs In on Social Media

The FDA recently issued two draft guidances on the use of social medial by pharmaceutical and biotechnology companies. One focuses on presenting risk-and-benefit information for drugs or devices and the other offers advice for dealing with misinformation spread on third-party sites. (For more on this, click here.)

Do you think the FDA needs to have as strict a stance on social media outlets as it does on traditional communication modes of regulatory information?

Yes
 
  67.2%
No
 
  32.8%

More Polls » View Results »

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Climate Change and Disease

Are the incursions of dengue fever and West Nile virus into North America just the tip of the iceberg of insect-borne diseases that are migrating due to a warming planet?